OURLab and its parent company, Prost Data, Inc., of Nashville, Tennessee, entered into an agreement to be sold to Opko Health Inc., of Miami, Florida. The purchase price of $40 million will be paid as $9.4 million in cash and $30.6 million in stock. Publicly-traded Opko has both pharmaceutical and diagnostic product lines. Jonathan Oppenheimer, …
October 29, 2012 “Intelligence: Late Breaking Lab News” Read More »
To access this post, you must purchase The Dark Report.